semaglutide and pancreatitis risk The package insert for Ozempic (Semaglutide) carries a black box warning for thyroid tumors — the FDA's most serious glp-1 law firm in kentucky

Patients should inform prescribers about levothyroxine use and report symptoms suggesting thyroid dysfunction or serious adverse effects promptly to their GP or endocrinologist

As we reported here, on September 16, 2025, FDA published over 55 warning letters to online sellers of compounded versions of GLP-1, the popular weight-loss injections marketed as Wegovy (semaglutide injection, manufactured by Novo Nordisk) and Zepbound (tirzepatide injection, manufactured by Eli Lilly)

Sustainable Brands

Rare but more serious side effects include pancreatitis and hypoglycaemia when combined with insulin or sulfonylureas